J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 28,782 shares at $4.37 ($126K) on 2024-01-09, disclosed to the SEC on 2024-01-10.
Seasonal sale ($126k) by President and CEO — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.37 | 14,391 | $63K | 50.0% |
| 2 | $4.37 | 14,391 | $63K | 50.0% |
| Total | $4.37 avg | 28,782 | $126K | 100% |
| Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |
| FATE | SELL | 2022-01-13 | $1.4M | — | Filing → |